dna
vaccin
use
vector
express
gagpol
env
gene
felin
leukaemia
viru
felv
plasmid
encod
felin
complet
protect
cat
viraemia
follow
challeng
hanlon
l
argyl
bain
nicolson
l
dunham
golder
mc
et
al
felin
leukaemia
viru
dna
vaccin
efficaci
enhanc
coadministr
express
vector
j
virol
howev
rel
contribut
cytokin
gene
toward
protect
unknown
studi
aim
resolv
issu
construct
modifi
ensur
effect
express
bioactiv
demonstr
use
specif
assay
kitten
immunis
intramuscularli
felv
dna
variou
cytokin
construct
togeth
control
kitten
challeng
oronas
felv
monitor
week
six
kitten
given
felv
protect
establish
persist
viraemia
four
latent
infect
six
kitten
immunis
felv
dna
protect
viraemia
five
latent
infect
contrast
three
five
kitten
given
felv
dna
becam
persist
viraem
therefor
adjuv
effect
felv
dna
vaccin
appear
resid
express
felin
leukaemia
viru
felv
common
retroviru
cat
major
caus
death
viru
spread
mainli
via
saliva
nasal
secret
infect
result
one
sever
outcom
cat
mount
suffici
power
immun
respons
recov
usual
develop
viru
neutralis
antibodi
vnab
felvspecif
cytotox
cell
ctl
infect
cat
mount
adequ
immun
respons
usual
anerg
viru
becom
persist
viraem
viraem
cat
succumb
felvrel
diseas
within
year
infect
mani
anim
ostens
recov
develop
latent
infect
viru
restrict
host
immun
respons
bone
marrow
probabl
tissu
major
case
viru
elimin
bone
marrow
within
month
exposur
case
may
persist
may
reactiv
anim
immunosuppress
treat
corticosteroid
felv
infect
control
field
detect
isol
viraem
cat
recent
also
vaccin
sever
type
felv
vaccin
avail
use
pet
cat
includ
inactiv
adjuv
whole
viru
inactiv
nonadjuv
whole
viru
inactiv
adjuv
virion
subunit
adjuv
recombin
felv
subunit
live
canarypoxfelv
recombin
express
felv
gag
env
gene
howev
commerci
avail
felv
vaccin
provid
complet
protect
persist
infect
latent
bone
marrow
infect
clearli
need
effect
product
studi
immun
respons
felv
shown
recoveri
infect
associ
initi
develop
virusspecif
ctl
follow
appear
vnab
follow
therefor
vaccin
design
stimul
cellmedi
immun
dna
vaccin
may
particularli
use
block
initi
stage
felv
infect
inde
dna
vaccin
consist
plasmid
vector
encod
gagpol
env
gene
protect
cat
establish
persist
viraemia
latenc
administ
togeth
plasmid
encod
felin
rational
use
cytokin
act
synergist
natur
killer
nk
cell
stimul
product
interferongamma
mediat
induct
ctl
previou
vaccin
studi
anim
protect
vaccin
higher
virusspecif
effector
ctl
peripher
blood
lymphoid
organ
cat
becam
persist
viraem
howev
rel
contribut
cytokin
efficaci
vaccin
establish
construct
alon
combin
felv
dna
test
efficaci
failur
construct
act
adjuv
might
due
inappropri
express
subunit
order
resolv
issu
carri
studi
use
improv
cytokin
construct
test
efficaci
genet
adjuv
independ
well
togeth
felin
assembl
two
protein
subunit
subunit
abl
form
homodim
molecul
bind
receptor
without
promot
activ
therebi
act
physiolog
antagonist
effect
may
influenc
result
previou
studi
gener
express
vector
contain
two
subunit
link
peptid
linker
sequenc
order
prevent
antagon
express
bioactiv
construct
vitro
also
demonstr
synthesis
biolog
inact
precursor
must
cleav
facilit
secret
activ
recent
perform
use
fuse
signal
sequenc
human
receptor
antagonist
protein
ilrap
end
felin
gene
express
bioactiv
construct
vitro
shown
western
blot
analysi
bioassay
respect
use
new
construct
determin
whether
protect
elicit
combin
cytokin
adjuv
felv
dna
vaccin
due
synergist
effect
due
either
cytokin
act
alon
cultur
media
supplement
purchas
invitrogen
life
technolog
paisley
uk
unless
otherwis
state
cell
maintain
c
atmospher
co
detect
felv
vnab
perform
use
cell
line
human
renal
epitheli
cell
line
express
simian
viru
cell
recov
equin
lymph
node
maintain
describ
previous
felv
challeng
viru
biolog
clone
cultur
fea
cell
describ
previous
batch
viru
use
titr
focu
form
unit
ffu
ml
rabbit
antifelin
peptid
antibodi
kindli
provid
virgil
schijn
intervet
intern
bv
gener
use
amino
acid
peptid
sequenc
felin
subunit
antirabbit
horseradish
peroxidas
hrp
mous
monoclon
antiprotein
antibodi
purchas
sigma
mous
antihuman
antibodi
crossreact
felin
bd
pharmingen
felv
dna
vaccin
consist
combin
two
dna
plasmid
one
encod
gagpol
cmvt
gagpol
encod
env
cmvt
env
previous
describ
clone
felin
signal
describ
previous
felin
singl
chain
fusion
construct
subunit
link
peptid
linker
sequenc
maxim
bioactiv
murin
found
encod
end
construct
felin
synthesis
pfu
pcr
use
follow
primer
primer
primer
primer
primer
primer
incorpor
partial
peptid
linker
sequenc
unit
engin
nar
restrict
site
gener
full
length
felin
clone
mammalian
express
vector
pcineo
promega
express
bioactiv
felin
vitro
shown
western
blot
bioassay
respect
vitro
express
felin
demonstr
western
blot
cell
separ
transfect
g
dna
felin
felin
pcineo
use
lipofectamin
reagent
invitrogen
life
technolog
accord
manufactur
instruct
transfect
harvest
h
felin
supernat
concentr
centrifug
omnifug
min
c
use
centriplu
cartridg
sampl
supernat
cell
lysat
produc
success
freezethaw
dri
ice
ethanol
electrophores
denatur
condit
sdspage
gel
transfer
pvdf
hybondp
membran
amersham
pharmacia
biotech
immunoblot
membran
expos
primari
antibodi
rabbit
antifelin
peptid
dilut
secondari
antibodi
antirabbit
hrp
concentr
bioactiv
felin
shown
previous
describ
equin
briefli
equin
lymph
node
cell
store
liquid
nitrogen
thaw
rapidli
supplement
ad
cell
seed
onto
plate
incub
h
c
tenfold
dilut
pcineo
transfect
sampl
prepar
triplic
also
triplic
dilut
ngml
mous
antihuman
felin
crossreact
antibodi
ngml
mous
antiprotein
prepar
sampl
incub
c
h
l
dilut
ad
cell
mix
gentli
cell
incub
c
h
equin
measur
use
sandwich
elisa
prepar
sheep
rabbit
polyclon
antibodi
rais
recombin
equin
express
bacteria
standard
curv
amount
recombin
equin
optic
densiti
use
establish
level
equin
induc
dilut
seri
dna
plasmid
cmvt
gagpol
cmvt
env
pcineo
purifi
describ
previous
endotoxin
level
batch
estim
use
limulu
amebocyt
lysat
techniqu
biowhittak
europ
threshold
level
endotoxin
taken
eumg
dna
dilut
endotoxinfre
pb
sigma
total
volum
ml
inocul
thirtyf
specificpathogen
free
kitten
purchas
commerci
sourc
arrang
randomli
six
group
six
apart
group
b
consist
five
anim
group
hous
separ
room
floor
area
height
studi
conduct
within
uk
home
offic
inspector
guidelin
anim
fed
commerci
food
sourc
water
anim
immunis
sampl
shown
fig
blood
sampl
collect
heparin
tube
plasma
separ
remov
storag
c
anim
challeng
accord
method
use
harbour
et
al
fig
viral
challeng
dilut
volum
ml
rpmi
administ
oronas
ml
nostril
ml
oral
anim
euthanas
week
postchalleng
blood
collect
anaesthesia
intracardiac
withdraw
bone
marrow
extract
femur
asept
techniqu
blood
bone
marrow
sampl
test
felv
blood
sampl
presenc
vnab
antifelv
antibodi
presenc
felv
establish
use
cell
bone
marrow
cell
cultur
day
test
presenc
felv
initi
cultur
cell
day
cell
subcultur
cultur
day
cultur
supernat
examin
presenc
felv
certain
point
trial
fig
presenc
vnab
establish
plasma
sampl
focu
reduct
protocol
plasma
sampl
taken
day
challeng
week
later
also
test
antibodi
felv
protein
western
blot
analysi
statist
analysi
perform
viru
isol
result
sum
total
posit
viru
isol
result
sum
total
neg
viru
isol
result
group
compar
use
fisher
exact
test
fe
test
test
calcul
exact
probabl
valu
relationship
two
dichotom
variabl
found
two
two
cross
tabl
comparison
vnab
titr
vaccin
group
perform
use
student
ttest
ensur
cytokin
gene
adjuv
includ
vaccin
effect
construct
use
hanlon
et
al
modifi
express
bioactiv
felin
describ
previous
present
studi
express
demonstr
western
blot
analysi
transfect
product
protein
supernat
fluid
cell
lysat
electrophores
sdspage
gel
transfer
pvdf
membran
incub
rabbit
antifelin
peptid
antibodi
follow
antirabbit
hrp
antibodi
fig
supernat
contain
kda
protein
correspond
protein
evid
cell
lysat
evid
subunit
supernat
protein
demonstr
transfect
supernat
indic
kda
band
bioactiv
transfect
supernat
analys
use
bioassay
measur
amount
equin
produc
respons
cell
graph
supernat
dilut
plot
fig
supernat
produc
sshape
dose
respons
curv
ensur
specif
respons
incub
supernat
mous
antihuman
neutralis
antibodi
move
curv
right
indic
stimul
suppress
incub
antiprotein
nonneutralis
antibodi
effect
produc
modifi
cytokin
construct
use
adjuv
felv
dna
vaccin
level
protect
induc
vaccin
assess
abil
prevent
infect
viral
challeng
persist
infect
cat
defin
one
infecti
viru
could
isol
plasma
week
challeng
end
trial
transient
infect
occur
cat
viraem
point
postchalleng
subsequ
becom
neg
remain
free
viru
remaind
experi
latent
infect
detect
isol
viru
cultur
bone
marrow
cell
cat
viraem
end
experi
group
studi
shown
tabl
viru
isol
carri
blood
sampl
taken
interv
postchalleng
cultur
fluid
harvest
cell
grown
bone
marrow
sampl
tabl
thu
incid
persist
latent
total
felv
infect
vaccin
group
assess
tabl
studi
instanc
transient
infect
three
week
challeng
three
six
unvaccin
control
cat
group
f
viraem
cat
number
becam
viraem
week
challeng
four
anim
persist
infect
termin
studi
latent
infect
detect
remain
two
nonviraem
unvaccin
cat
end
studi
anim
inocul
felv
dna
vaccin
alon
group
four
cat
viraem
week
challeng
remain
latent
infect
detect
one
addit
nonviraem
anim
group
therefor
felv
dna
vaccin
alon
group
provid
protect
persist
infect
compar
unvaccin
control
anim
group
f
howev
dna
vaccin
reduc
level
latent
infect
group
comparison
unvaccin
anim
although
given
small
number
anim
involv
exper
iment
definit
conclus
drawn
data
control
anim
inocul
group
e
three
cat
persist
infect
postchalleng
three
remain
anim
two
found
latent
infect
although
fewer
cat
infect
result
suggest
cytokin
alon
provid
signific
protect
challeng
conclus
neither
dna
vaccin
cytokin
gene
adjuv
alon
provid
signific
protect
persist
latent
infect
kitten
immunis
gene
adjuv
group
consist
free
viraemia
throughout
experi
two
six
cat
cat
latent
infect
viru
adjuv
combin
therefor
elicit
high
level
protect
compar
combin
level
viraemia
latent
infect
unvaccin
anim
fe
test
p
group
b
compris
kitten
given
felv
dna
five
vaccin
cat
three
persist
infect
week
postchalleng
bone
marrow
group
analys
viru
isol
viraem
cat
two
nonviraem
anim
result
compar
level
infect
unvaccin
anim
inject
dna
vaccin
alon
indic
dna
enhanc
efficaci
felv
dna
vaccin
tabl
plasma
antifelv
antibodi
cat
termin
experi
weak
posit
antibodi
band
repres
strong
band
kitten
group
c
inocul
gene
adjuv
felv
dna
vaccin
viru
detect
blood
six
anim
postchalleng
compar
four
anim
control
group
f
p
one
cat
number
found
harbour
felv
bone
marrow
total
persist
latent
infect
vaccin
group
assess
one
anim
group
c
infect
compar
six
unvaccin
cat
group
f
fe
test
p
five
anim
inocul
vaccin
alon
group
fe
test
p
result
strongli
suggest
dna
enhanc
efficaci
dna
vaccin
dna
vaccin
combin
extrem
effect
vaccin
felv
infect
result
stastic
signific
combin
persist
latent
infect
combin
level
protect
afford
two
vaccin
contain
addit
felv
dna
high
order
determin
vaccin
induc
sterilis
immun
assay
antifelv
antibodi
carri
plasma
kitten
cours
vaccin
day
challeng
week
later
end
trial
experi
similar
dna
vaccin
cat
anticip
none
dna
vaccin
would
induc
antibodi
consequ
induct
sterilis
immun
vaccin
result
block
replic
challeng
viru
might
follow
appear
antivir
antibodi
plasma
result
assay
vnab
antibodi
individu
felv
protein
detect
western
blot
shown
tabl
none
kitten
antibodi
follow
vaccin
contrast
week
challeng
nearli
kitten
antibodi
least
one
assay
indic
experienc
viru
growth
expect
vnab
present
almost
nonviraem
cat
persist
infect
cat
median
vnab
titr
protect
cat
group
c
receiv
felv
dna
dna
compar
nonviraem
cat
group
e
f
receiv
control
prepar
howev
differ
signific
ttest
p
immunoblot
antibodi
su
ca
tm
could
identifi
clear
differ
respons
cat
group
confirm
find
hanlon
et
al
vaccin
contain
felv
gagpol
env
gene
togeth
cytokin
gene
adjuv
provid
complet
protect
felv
viraemia
cat
rational
use
particular
cytokin
induc
cellmedi
immun
respons
time
believ
respons
protect
felv
infect
known
involv
cytokin
promot
type
immun
respons
act
synergist
enhanc
express
pleotrop
cytokin
crucial
normal
function
cellmedi
immun
previou
felv
dna
vaccin
studi
rel
role
cytokin
gene
establish
group
cat
vaccin
felv
dna
alon
includ
vaccin
trial
doubt
efficaci
construct
particular
sinc
subunit
express
separ
plasmid
possibl
homodim
format
antagonis
activ
inhibit
adjuv
effect
cytokin
therefor
present
studi
primari
aim
modifi
cytokin
construct
felin
show
cytokin
express
high
level
vitro
bioactiv
prior
use
vaccin
experi
clone
felin
origin
design
use
clone
human
murin
construct
two
subunit
link
peptid
linker
sequenc
glyglyglyglys
minu
leader
sequenc
downstream
subunit
sever
construct
report
includ
subunit
encod
separ
plasmid
subunit
encod
tandem
varieti
promot
system
use
intern
ribosom
entri
site
sequenc
subunit
selfcleav
peptid
footandmouth
diseas
viru
howev
structur
ensur
product
equimolar
amount
subunit
homodim
format
prevent
studi
murin
construct
found
subunit
situat
upstream
elicit
highest
level
bioactiv
construct
accordingli
felin
design
way
synthesis
releas
transfect
cell
degrad
releas
protein
subunit
bioactiv
product
verifi
use
assay
product
equin
lymph
node
cell
ideal
assay
measur
product
felin
cell
use
howev
cell
short
suppli
consequ
attempt
develop
felin
specif
assay
unsuccess
use
neutralis
nonneutralis
antibodi
assay
provid
evid
stimul
specif
felin
protein
present
sampl
use
vaccin
trial
believ
improv
construct
use
previous
modifi
plasmid
shown
express
high
level
secret
transfect
cell
bioactiv
western
blot
analysi
bioassay
vitro
felv
dna
compon
vaccin
consist
combin
two
plasmid
vector
cmvt
gagpol
cmvt
env
vaccin
ident
use
previou
trial
contain
viral
gene
felv
shown
gene
express
vitro
cotransfect
plasmid
produc
viruslik
particl
capabl
infect
suscept
cell
modif
preced
vaccin
studi
use
oronas
rout
rather
intraperiton
rout
administr
challeng
viru
oronas
administr
prefer
method
close
simul
natur
infect
intraperiton
inocul
use
previous
consid
import
establish
whether
vaccin
administ
parenter
inocul
could
protect
challeng
natur
mucos
rout
order
overcom
natur
resist
oronas
felv
infect
develop
kitten
age
use
trial
protocol
employ
fraction
dose
viru
given
period
day
previous
cat
develop
persist
viraemia
use
schedul
present
studi
nonvaccin
control
kitten
becam
persist
viraem
per
se
made
comparison
efficaci
vaccin
difficult
small
number
anim
group
howev
remain
two
cat
latent
infect
comparison
base
total
number
overt
covert
infect
allow
meaning
comparison
made
major
aim
establish
whether
immun
protect
afford
felv
dna
vaccin
due
synerg
two
cytokin
due
singl
cytokin
act
alon
clearli
combin
cytokin
gene
togeth
felv
dna
provid
excel
protect
also
found
alon
suffici
potent
adjuv
protect
anim
persist
viraemia
latent
infect
wherea
adjuv
produc
signific
protect
result
line
studi
virus
fail
demonstr
posit
effect
dna
vaccin
includ
fiv
felin
coronaviru
japanes
enceph
viru
jev
inde
studi
inhibit
antivir
immun
respons
found
certain
case
immunosuppress
relat
dose
dna
time
administr
thu
high
dose
recombin
murin
increas
suscept
mice
lymphocyt
choriomening
viru
wherea
lower
dose
enhanc
immun
respons
adenoviru
vector
express
enhanc
cellular
immun
respons
hepat
c
vaccin
higher
dose
abrog
effect
addit
immunosuppress
induc
administ
togeth
jev
given
immunis
present
studi
evid
deliveri
construct
effect
vaccin
infect
inhibit
adjuv
effect
thu
effect
outcom
challeng
administ
alon
felvdna
felv
dna
ilrap
although
construct
express
vitro
sure
high
level
express
vivo
like
compon
vaccin
effect
adjuv
mani
studi
shown
posit
effect
dna
gene
adjuv
dna
vaccin
predomin
function
immun
system
stimul
immun
respons
product
also
enhanc
prolifer
cell
dosedepend
manner
effect
depend
addit
cytokin
select
enhanc
fa
ligand
fasl
mediat
cytotox
murin
cell
stimul
perforindepend
cytotox
nk
cell
therefor
function
explain
impress
protect
effect
observ
studi
gene
adjuv
enhanc
cellmedi
immun
respons
shown
vital
resist
felv
particularli
earli
stage
viral
infect
cellular
immun
respons
probabl
mediat
ctl
alon
suffici
protect
cat
felv
infect
previou
trial
none
vaccin
induc
vnab
challeng
fact
commerci
felv
vaccin
consist
induc
vnab
although
nonneutralis
antibodi
antigen
vaccin
elicit
analysi
felin
dna
vaccin
experi
document
show
vari
humor
respons
antigen
concern
one
case
minimalist
immunogen
defin
gene
express
vector
express
fiv
felin
elicit
protect
without
produc
specif
humor
respons
howev
dna
plasmid
encod
fiv
found
induc
virusspecif
antibodi
respons
evid
suggest
particular
viral
antigen
use
well
vaccin
schedul
rout
administr
strong
influenc
presenc
type
immun
respons
produc
includ
develop
specif
antibodi
level
protect
achiev
trial
high
due
sterilis
immun
sinc
antifelv
antibodi
produc
cat
follow
challeng
howev
median
vnab
titr
kitten
vaccin
felv
dna
dna
resist
challeng
lower
cat
control
group
becom
viraem
although
differ
titr
significantli
differ
result
give
indic
viru
growth
might
inhibit
vaccin
kitten
immedi
follow
challeng
overal
studi
show
two
cytokin
adjuv
use
combin
felv
dna
vaccin
domin
activ
factor
respons
elicit
protect
viral
challeng
